Gene Therapy Analytical Development Europe Summit

As gene therapy biopharma wrestles to demonstrate clinical efficacy and product safety, the need to develop robust and efficient analytical tools has never been greater. In the face evolving regulatory guidelines and mounting scrutiny, the 4th Gene Therapy Analytical Development Europe Summit will showcase best-in-class data and case study driven content to ensure you can develop sound analytical tools that guarantee the consistency, quality and safety of your gene therapy product and ultimately support your product getting to the market faster.

Uniting leading CMC, Regulatory, QC, Analytical and Process Development experts, the 4^th Gene Therapy Analytical Development Europe Summit is the industry’s definitive and only meeting focused on tackling the greatest analytical development challenges in the context of gene therapy drug development.